CCL2/MCP-1 modulation of microglial activation and proliferation

Journal of Neuroinflammation

Volumn 8, Issue , 2011, Pages

  Hinojosa, Ara E ^a,b   Garcia Bueno, Borja ^a,b   Leza, Juan C ^a,b   Madrigal, Jose L M ^a,b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b Instituto de Investigación Sanitaria Hospital 12 de Octubre ^*  (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRITE; CCL2 PROTEIN, RAT; CELL CYCLE PROTEIN; CYTOKINE; SIGNAL PEPTIDE;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL DEATH; CELL PROLIFERATION; CELL STRUCTURE; COCULTURE; CONTROLLED STUDY; FETUS; MICROGLIA; NERVE CELL; NERVE CELL CULTURE; NEUROTOXICITY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REGULATORY MECHANISM; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG EFFECT; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; WISTAR RAT;

ANIMALS; CELL CYCLE PROTEINS; CELL PROLIFERATION; CELLS, CULTURED; CHEMOKINE CCL2; CYTOKINES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICROGLIA; NEURONS; RATS; RATS, WISTAR;

EID: 79959835836     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-8-77     Document Type: Article

References (51)

1. Luster AD, Alon R, von Andrian UH. Immune cell migration in inflammation: present and future therapeutic targets. Nat Immunol 2005, 6:1182-1190. 10.1038/ni1275, 16369557.
2. Rot A, von Andrian UH. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol 2004, 22:891-928. 10.1146/annurev.immunol.22.012703.104543, 15032599.
3. Gerard C, Rollins BJ. Chemokines and disease. Nat Immunol 2001, 2:108-115. 10.1038/84209, 11175802.
4. Amor S, Puentes F, Baker D, van d V. Inflammation in neurodegenerative diseases. Immunology 2010, 129:154-169. 10.1111/j.1365-2567.2009.03225.x, 2814458, 20561356.
5. Ransohoff RM, Perry VH. Microglial physiology: unique stimuli, specialized responses. Annu Rev Immunol 2009, 27:119-145. 10.1146/annurev.immunol.021908.132528, 19302036.
6. Streit WJ, Xue QS. Life and death of microglia. J Neuroimmune Pharmacol 2009, 4:371-379. 10.1007/s11481-009-9163-5, 19680817.
7. Wake H, Moorhouse AJ, Jinno S, Kohsaka S, Nabekura J. Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J Neurosci 2009, 29:3974-3980. 10.1523/JNEUROSCI.4363-08.2009, 19339593.
8. Block ML, Hong JS. Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol 2005, 76:77-98. 10.1016/j.pneurobio.2005.06.004, 16081203.
9. Ambrosini E, Aloisi F. Chemokines and glial cells: a complex network in the central nervous system. Neurochem Res 2004, 29:1017-1038.
10. Yadav A, Saini V, Arora S. MCP-1:chemoattractant with a role beyond immunity: a review. Clin Chim Acta 2010, 411:1570-1579. 10.1016/j.cca.2010.07.006, 20633546.
11. Bruno V, Copani A, Besong G, Scoto G, Nicoletti F. Neuroprotective activity of chemokines against N-methyl-D-aspartate or beta-amyloid-induced toxicity in culture. Eur J Pharmacol 2000, 399:117-121. 10.1016/S0014-2999(00)00367-8, 10884510.
12. El KJ, Toft M, Hickman SE, Means TK, Terada K, Geula C, et al. Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat Med 2007, 13:432-438. 10.1038/nm1555, 17351623.
13. Eugenin EA, D'Aversa TG, Lopez L, Calderon TM, Berman JW. MCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosis. J Neurochem 2003, 85:1299-1311. 10.1046/j.1471-4159.2003.01775.x, 12753088.
14. Guyon A, Skrzydelski D, De G, Rovere C, Conductier G, Trocello JM, et al. Long term exposure to the chemokine CCL2 activates the nigrostriatal dopamine system: a novel mechanism for the control of dopamine release. Neuroscience 2009, 162:1072-1080. 10.1016/j.neuroscience.2009.05.048, 19477239.
15. Kalehua AN, Nagel JE, Whelchel LM, Gides JJ, Pyle RS, Smith RJ, et al. Monocyte chemoattractant protein-1 and macrophage inflammatory protein-2 are involved in both excitotoxin-induced neurodegeneration and regeneration. Exp Cell Res 2004, 297:197-211. 10.1016/j.yexcr.2004.02.031, 15194436.
16. Omata N, Yasutomi M, Yamada A, Iwasaki H, Mayumi M, Ohshima Y. Monocyte chemoattractant protein-1 selectively inhibits the acquisition of CD40 ligand-dependent IL-12-producing capacity of monocyte-derived dendritic cells and modulates Th1 immune response. J Immunol 2002, 169:4861-4866.
17. Melik-Parsadaniantz S, Rostene W. Chemokines and neuromodulation. J Neuroimmunol 2008, 198:62-68. 10.1016/j.jneuroim.2008.04.022, 18538863.
18. Vairano M, Dello RC, Pozzoli G, Battaglia A, Scambia G, Tringali G, et al. Erythropoietin exerts anti-apoptotic effects on rat microglial cells in vitro. Eur J Neurosci 2002, 16:584-592. 10.1046/j.1460-9568.2002.02125.x, 12270034.
19. Madrigal JL, Feinstein DL, Dello RC. Norepinephrine protects cortical neurons against microglial-induced cell death. J Neurosci Res 2005, 81:390-396. 10.1002/jnr.20481, 15948176.
20. Kloss CU, Bohatschek M, Kreutzberg GW, Raivich G. Effect of lipopolysaccharide on the morphology and integrin immunoreactivity of ramified microglia in the mouse brain and in cell culture. Exp Neurol 2001, 168:32-46. 10.1006/exnr.2000.7575, 11170719.
21. McQuibban GA, Gong JH, Wong JP, Wallace JL, Clark-Lewis I, Overall CM. Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. Blood 2002, 100:1160-1167.
22. Yao Y, Tsirka SE. The C terminus of mouse monocyte chemoattractant protein 1 (MCP1) mediates MCP1 dimerization while blocking its chemotactic potency. J Biol Chem 2010, 285:31509-31516. 10.1074/jbc.M110.124891, 20682771.
23. Belmadani A, Tran PB, Ren D, Miller RJ. Chemokines regulate the migration of neural progenitors to sites of neuroinflammation. J Neurosci 2006, 26:3182-3191. 10.1523/JNEUROSCI.0156-06.2006, 2740990, 16554469.
24. Zhou Y, Tang H, Liu J, Dong J, Xiong H. Chemokine CCL2 modulation of neuronal excitability and synaptic transmission in rat hippocampal slices. J Neurochem 2011, 116:406-414. 10.1111/j.1471-4159.2010.07121.x, 21105875.
25. Yoshie O, Imai T, Nomiyama H. Chemokines in immunity. Adv Immunol 2001, 78:57-110.
26. Thompson WL, Karpus WJ, Van Eldik LJ. MCP-1-deficient mice show reduced neuroinflammatory responses and increased peripheral inflammatory responses to peripheral endotoxin insult. J Neuroinflammation 2008, 5:35. 10.1186/1742-2094-5-35, 2527558, 18706086.
27. Deshmane SL, Kremlev S, Amini S, Sawaya BE. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res 2009, 29:313-326. 10.1089/jir.2008.0027, 2755091,2755091, 19441883.
28. Rezaie P, Trillo-Pazos G, Everall IP, Male DK. Expression of beta-chemokines and chemokine receptors in human fetal astrocyte and microglial co-cultures: potential role of chemokines in the developing CNS. Glia 2002, 37:64-75. 10.1002/glia.1128, 11746784.
29. Madrigal JL, Leza JC, Polak P, Kalinin S, Feinstein DL. Astrocyte-derived MCP-1 mediates neuroprotective effects of noradrenaline. J Neurosci 2009, 29:263-267. 10.1523/JNEUROSCI.4926-08.2009, 19129402.
30. Yang G, Meng Y, Li W, Yong Y, Fan Z, Ding H, et al. Neuronal MCP-1 Mediates Microglia Recruitment and Neurodegeneration Induced by the Mild Impairment of Oxidative Metabolism. Brain Pathol 2010,
31. Thacker MA, Clark AK, Bishop T, Grist J, Yip PK, Moon LD, et al. CCL2 is a key mediator of microglia activation in neuropathic pain states. Eur J Pain 2009, 13:263-272. 10.1016/j.ejpain.2008.04.017, 18554968.
32. Muessel MJ, Klein RM, Wilson AM, Berman NE. Ablation of the chemokine monocyte chemoattractant protein-1 delays retrograde neuronal degeneration, attenuates microglial activation, and alters expression of cell death molecules. Brain Res Mol Brain Res 2002, 103:12-27.
33. Yokoyama A, Yang L, Itoh S, Mori K, Tanaka J. Microglia, a potential source of neurons, astrocytes, and oligodendrocytes. Glia 2004, 45:96-104. 10.1002/glia.10306, 14648550.
34. Kauppinen TM, Swanson RA. Poly(ADP-ribose) polymerase-1 promotes microglial activation, proliferation, and matrix metalloproteinase-9-mediated neuron death. J Immunol 2005, 174:2288-2296.
35. Mander P, Brown GC. Activation of microglial NADPH oxidase is synergistic with glial iNOS expression in inducing neuronal death: a dual-key mechanism of inflammatory neurodegeneration. J Neuroinflammation 2005, 2:20. 10.1186/1742-2094-2-20, 1232863, 16156895.
36. Graeber MB, Streit WJ. Microglia: biology and pathology. Acta Neuropathol 2010, 119:89-105. 10.1007/s00401-009-0622-0, 20012873.
37. Shimojo M, Nakajima K, Takei N, Hamanoue M, Kohsaka S. Production of basic fibroblast growth factor in cultured rat brain microglia. Neurosci Lett 1991, 123:229-231. 10.1016/0304-3940(91)90937-O, 2027536.
38. Lalancette-Hebert M, Gowing G, Simard A, Weng YC, Kriz J. Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J Neurosci 2007, 27:2596-2605. 10.1523/JNEUROSCI.5360-06.2007, 17344397.
39. Morrison RS, Sharma A, de VJ, Bradshaw RA. Basic fibroblast growth factor supports the survival of cerebral cortical neurons in primary culture. Proc Natl Acad Sci USA 1986, 83:7537-7541. 10.1073/pnas.83.19.7537, 386754, 3463983.
40. Walicke P, Cowan WM, Ueno N, Baird A, Guillemin R. Fibroblast growth factor promotes survival of dissociated hippocampal neurons and enhances neurite extension. Proc Natl Acad Sci USA 1986, 83:3012-3016. 10.1073/pnas.83.9.3012, 323437, 3458259.
41. Aberg ND, Brywe KG, Isgaard J. Aspects of growth hormone and insulin-like growth factor-I related to neuroprotection, regeneration, and functional plasticity in the adult brain. ScientificWorldJournal 2006, 6:53-80.
42. O'Donnell SL, Frederick TJ, Krady JK, Vannucci SJ, Wood TL. IGF-I and microglia/macrophage proliferation in the ischemic mouse brain. Glia 2002, 39:85-97. 10.1002/glia.10081, 12112378.
43. Perez-Martin M, Cifuentes M, Grondona JM, Lopez-Avalos MD, Gomez-Pinedo U, Garcia-Verdugo JM, et al. IGF-I stimulates neurogenesis in the hypothalamus of adult rats. Eur J Neurosci 2010, 31:1533-1548.
44. Chiu K, Yeung SC, So KF, Chang RC. Modulation of morphological changes of microglia and neuroprotection by monocyte chemoattractant protein-1 in experimental glaucoma. Cell Mol Immunol 2010, 7:61-68. 10.1038/cmi.2009.110, 20081877.
45. Zhang J, Shi XQ, Echeverry S, Mogil JS, De KY, Rivest S. Expression of CCR2 in both resident and bone marrow-derived microglia plays a critical role in neuropathic pain. J Neurosci 2007, 27:12396-12406. 10.1523/JNEUROSCI.3016-07.2007, 17989304.
46. Kalinin S, Gavrilyuk V, Polak PE, Vasser R, Zhao J, Heneka MT, et al. Noradrenaline deficiency in brain increases beta-amyloid plaque burden in an animal model of Alzheimer's disease. Neurobiol Aging 2007, 28:1206-1214. 10.1016/j.neurobiolaging.2006.06.003, 16837104.
47. Heneka MT, Ramanathan M, Jacobs AH, Dumitrescu-Ozimek L, Bilkei-Gorzo A, Debeir T, et al. Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice. J Neurosci 2006, 26:1343-1354. 10.1523/JNEUROSCI.4236-05.2006, 16452658.
48. Madrigal JL, Dello RC, Gavrilyuk V, Feinstein DL. Effects of noradrenaline on neuronal NOS2 expression and viability. Antioxid Redox Signal 2006, 8:885-892. 10.1089/ars.2006.8.885, 16771678.
49. Bondareff W, Mountjoy CQ, Roth M. Selective loss of neurones of origin of adrenergic projection to cerebral cortex (nucleus locus coeruleus) in senile dementia. Lancet 1981, 1:783-784.
50. Fornai F, di Poggio AB, Pellegrini A, Ruggieri S, Paparelli A. Noradrenaline in Parkinson's disease: from disease progression to current therapeutics. Curr Med Chem 2007, 14:2330-2334. 10.2174/092986707781745550, 17896981.
51. Polak PE, Kalinin S, Feinstein DL. Locus coeruleus damage and noradrenaline reductions in multiple sclerosis and experimental autoimmune encephalomyelitis. Brain 2011, 134:665-677. 10.1093/brain/awq362, 21297130.